Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis

Summary

Fatigue is a common symptom in multiple sclerosis (MS) that is characterized by physical and/or mental exhaustion. Fatigue is difficult to treat and treatment efficacy of available therapy is limited. The goal of this study is to determine whether MS-associated fatigue improves after 6 weeks of methylphenidate therapy. Treatment efficacy will be measured by a questionnaire called "Fatigue Severity Scale" (FSS).

Timeline

Start

2012-12

Primary completion

2017-02

Completion

2017-02

Drugs

Indications